Enteropathy-associated T-cell lymphoma primary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Nnasiri}} | {{CMG}} {{AE}}{{Nnasiri}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of enteropathy-associated T cell lymphoma. | |||
==Primary Prevention== | ==Primary Prevention== | ||
*There are no established measures for the primary prevention of enteropathy-associated T cell lymphoma. | *There are no established measures for the primary prevention of enteropathy-associated T cell lymphoma. | ||
==Refrences== | ==Refrences== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 13:11, 8 March 2019
Enteropathy-associated T-cell lymphoma Microchapters |
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Enteropathy-associated T-cell lymphoma primary prevention On the Web |
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma primary prevention |
FDA on Enteropathy-associated T-cell lymphoma primary prevention |
CDC on Enteropathy-associated T-cell lymphoma primary prevention |
Enteropathy-associated T-cell lymphoma primary prevention in the news |
Blogs on Enteropathy-associated T-cell lymphoma primary prevention |
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
There are no established measures for the primary prevention of enteropathy-associated T cell lymphoma.
Primary Prevention
- There are no established measures for the primary prevention of enteropathy-associated T cell lymphoma.